Costa Rica Constitution Court Issues Final Ultimatum for ENDS Regulation

Jun.20.2024
Costa Rica Constitution Court Issues Final Ultimatum for ENDS Regulation
Costa Rica's Constitutional Court issues final ultimatum to Health Ministry to regulate e-cigarettes and tobacco products within two months.

According to La Nacion's report on June 18th, the Constitutional Court of Costa Rica has issued a final ultimatum to the Ministry of Health, demanding that it publish Regulation No. 10,066 within two months. This regulation governs the management of electronic nicotine delivery systems (ENDS), non-nicotine similar systems (SSSN), and the use of heated tobacco and e-cigarettes.


In resolution number 2024016580 issued on June 14th, the Constitutional Court accepted a lawsuit filed by lawyer Walter Brenes Soto on May 24th. Brenes argued to the judges that despite Law 10,066 being published in "La Gaceta" on January 20th, 2022, two years later there were still no corresponding regulations in place, which he believed infringed on the basic rights of citizens. The judges agreed with Brenes' argument and ordered the Ministry of Health to establish the necessary regulations. The Ministry of Health has two months from receiving the notification to complete this task.


The Ministry of Health has provided an explanation for this. After the regulation was announced in 2022, the Ministry of Health had three months to develop the regulation. However, due to the need to consult with other relevant public institutions and the necessity to navigate the typical transitions brought on by a change in government, the Ministry of Health stated that it was unable to complete the task within the specified time frame. Deputy Minister of Health Allan Mora Vargas presented these reasons in defense of the ministry's inability to do so in a statement to the Constitutional Court judge and included them in case file 24-013568-0007-CO.


According to a report from the Ministry of Health, the regulatory proposal number 10,066 has been completed and is now awaiting review by the legal and regulatory department of the President's office before being signed by the President and published in "La Gaceta.


After analyzing the complaint, the Constitutional Court concluded that this regulation has a critical impact on the health rights of the people of Costa Rica. The court insisted that "alleged regulatory failures can constitute negligence declared within the jurisdiction of the constitution.


On May 14, 2024, the Ministry of Health issued a resolution prohibiting the import, use, sale, and operation of products containing synthetic nicotine. Health Minister Mary Munive Angermüller explained that the Ministry of Health, based on its authority and the principle of prevention, banned these e-cigarettes to prevent further harm to the public, as evidence shows that e-cigarettes containing nicotine levels exceeding European regulations are being sold in the Costa Rican market.


Resolution MS-DM-RC-2381-2024 prohibits the distribution, advertising, promotion, and sponsorship of products containing nicotine and associated accessories, as well as e-cigarette liquids containing cannabis derivatives. This regulation applies to all forms of media, whether through phone, digital, or any other means of accessing these devices and substances. The regulation will be enforced during the period in which the Ministry of Health issues technical regulations to control these devices and substances.


According to Angmuller's statement in May, this regulation is expected to be completed by the end of 2024.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
A Scottish government impact assessment estimates that proposed vape display and packaging rules could create up to £61 million ($82 million) in compliance costs for businesses, affecting more than 11,000 retail outlets. The estimated costs are mainly linked to inventory adjustments, retail storage changes and the resources required for businesses to understand and implement the new requirements. The measures form part of the UK’s broader efforts to tighten vape regulation, particularly around product displays, packaging and sales practices.
Aug.10